Maximus, Inc. $MMS Shares Sold by Robeco Schweiz AG

Robeco Schweiz AG lowered its stake in shares of Maximus, Inc. (NYSE:MMS) by 11.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 76,162 shares of the health services provider’s stock after selling 9,859 shares during the quarter. Robeco Schweiz AG’s holdings in Maximus were worth $6,574,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also modified their holdings of the company. Richardson Financial Services Inc. grew its stake in Maximus by 29.6% during the 4th quarter. Richardson Financial Services Inc. now owns 451 shares of the health services provider’s stock worth $39,000 after purchasing an additional 103 shares in the last quarter. Farther Finance Advisors LLC raised its position in Maximus by 69.0% in the 4th quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock valued at $25,000 after purchasing an additional 116 shares in the last quarter. Arizona State Retirement System boosted its stake in shares of Maximus by 0.9% in the 3rd quarter. Arizona State Retirement System now owns 16,674 shares of the health services provider’s stock valued at $1,524,000 after buying an additional 156 shares during the period. GAMMA Investing LLC boosted its stake in shares of Maximus by 13.8% in the 4th quarter. GAMMA Investing LLC now owns 1,522 shares of the health services provider’s stock valued at $131,000 after buying an additional 185 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Maximus by 0.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock valued at $2,351,000 after buying an additional 221 shares during the period. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on MMS shares. Zacks Research lowered shares of Maximus from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 27th. Wall Street Zen cut shares of Maximus from a “buy” rating to a “hold” rating in a report on Monday, February 23rd. Finally, Weiss Ratings downgraded shares of Maximus from a “buy (b)” rating to a “hold (c+)” rating in a research report on Tuesday, February 24th. Two investment analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Maximus presently has a consensus rating of “Hold”.

Maximus Stock Performance

Shares of Maximus stock opened at $64.08 on Thursday. The company has a quick ratio of 2.34, a current ratio of 2.34 and a debt-to-equity ratio of 0.88. Maximus, Inc. has a 52 week low of $60.75 and a 52 week high of $100.00. The firm’s 50 day moving average is $68.95 and its two-hundred day moving average is $80.14. The firm has a market capitalization of $3.50 billion, a P/E ratio of 9.75 and a beta of 0.60.

Maximus (NYSE:MMS) last issued its earnings results on Thursday, February 5th. The health services provider reported $1.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.84 by $0.01. Maximus had a net margin of 6.92% and a return on equity of 25.30%. The business had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.37 billion. During the same quarter in the prior year, the business posted $1.61 EPS. The company’s revenue for the quarter was down 4.1% on a year-over-year basis. Research analysts forecast that Maximus, Inc. will post 8.46 EPS for the current fiscal year.

Maximus Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 1st. Stockholders of record on Friday, May 15th will be issued a $0.33 dividend. This represents a $1.32 annualized dividend and a dividend yield of 2.1%. The ex-dividend date of this dividend is Friday, May 15th. Maximus’s dividend payout ratio is presently 20.09%.

Insiders Place Their Bets

In other Maximus news, CFO David Mutryn bought 1,000 shares of the firm’s stock in a transaction dated Monday, February 9th. The stock was acquired at an average price of $75.62 per share, for a total transaction of $75,620.00. Following the completion of the purchase, the chief financial officer owned 40,037 shares of the company’s stock, valued at approximately $3,027,597.94. This represents a 2.56% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Bruce Caswell purchased 3,175 shares of the company’s stock in a transaction that occurred on Tuesday, February 10th. The stock was bought at an average price of $78.45 per share, for a total transaction of $249,078.75. Following the transaction, the chief executive officer directly owned 328,013 shares in the company, valued at $25,732,619.85. This trade represents a 0.98% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 1.80% of the stock is currently owned by insiders.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.